Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Lilly/Incyte’s rheumatoid arthritis drug gets CHMP’s recommendation for EMA’s approval
December 16, 2016 Off

Lilly/Incyte’s rheumatoid arthritis drug gets CHMP’s recommendation for EMA’s approval

By Dino Mustafić

Eli Lilly and Incyte Corporation have gotten positive opinion from European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…

Mylan Launches generic for EpiPen adrenaline injection, fights rising US drug prices
December 16, 2016 Off

Mylan Launches generic for EpiPen adrenaline injection, fights rising US drug prices

By Dino Mustafić

Mylan is launching its generic for EpiPen adrenaline injection at a wholesale acquisition cost (WAC) of $300 per epinephrine injection. As…

Novartis’s epilepsy drug gets CHMP’s positive opinion
December 16, 2016 Off

Novartis’s epilepsy drug gets CHMP’s positive opinion

By Dino Mustafić

Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for…

ABIVAX welcomes Didier Blondel as CFO
December 16, 2016 Off

ABIVAX welcomes Didier Blondel as CFO

By Dino Mustafić

ABIVAX has appointed Didier Blondel as Chief Financial Officer, effective January 2nd, 2017.

FDA OK’s Cerenis’s CER-209 clinical trial for liver disease treatment
December 16, 2016 Off

FDA OK’s Cerenis’s CER-209 clinical trial for liver disease treatment

By Dino Mustafić

U.S. Food and Drug Administration (FDA) has given green light to Cerenis Therapeutics to proceed with CER-209 clinical trial.

Novartis buys Ziarco Group
December 16, 2016 Off

Novartis buys Ziarco Group

By Dino Mustafić

Novartis has entered into a definitive agreement to buy a privately held company Ziarco Group Limited, focused on producing dermatology…

RAC Approves Cellectis’s UCART123 Phase 1 study protocols in AML and BPDCN
December 16, 2016 Off

RAC Approves Cellectis’s UCART123 Phase 1 study protocols in AML and BPDCN

By Dino Mustafić

Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), has announced the National Institute…

MDxHealth Receives ISO 13485:2016 Certification for Dutch Laboratory
December 16, 2016 Off

MDxHealth Receives ISO 13485:2016 Certification for Dutch Laboratory

By Dino Mustafić

MDxHealth’s laboratory in Nijmegen, The Netherlands has received ISO 13485:2016 certification for the design, development, manufacture and distribution of in…

Allergan’s subsidiaries Forest to pay $38M for bad marketing practices
December 16, 2016 Off

Allergan’s subsidiaries Forest to pay $38M for bad marketing practices

By Dino Mustafić

Allergan’s indirect subsidiaries Forest Laboratories, LLS and Forest Pharmaceuticals, Inc. are about to pay $38 million for bad sales and…

Valneva closes private placement in connection with EUR15.2m investment by MVM
December 16, 2016 Off

Valneva closes private placement in connection with EUR15.2m investment by MVM

By Dino Mustafić

French vaccines developer Valneva has closed the share issuance in connection with MVM Life Science Partners LLP`s  investment in the…

Posts pagination

Previous 1 … 3,540 3,541 3,542 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine